Emedonline: Telemedicine Medication Management System

描述(由调查人员提供)：据估计，药物违规每年给美国医疗系统造成的损失估计为766亿美元。大约10%的住院与药物问题有关，每年的成本高达500亿美元。了解不依从性的原因并确定帮助患者遵循他们的方案的方法可能会改善健康结果并降低相关成本。我们建议确定药物管理系统是否能改善正在接受高血压治疗的老年患者的依从性。这个名为EmedOnline的药物管理系统使用标准的手机技术，每隔一段时间就给患者打电话，给出服用处方药的语音、文本和图形指令，并分发药物。它特别侧重于修改社会互动因素，并提供一种工具来加强行政管理过程。我们已经确定了实现第一阶段和第二阶段目标的三个关键目标：1.开发EmedOnline，以促进医疗保健提供者开出药物治疗方案，并促进患者的用药依从性。2.评估医疗服务提供者、药剂师和患者对服务的接受度。3.评估对服药依从性、感受到的社会支持和对健康命运的控制感的影响。在第一阶段，我们将通过医疗保健提供者、药剂师和患者样本的焦点小组检查需求；开发EmedOnline系统的原型；使用样本进行概念测试；并为第二阶段开发创建详细规范。

DESCRIPTION (provided by investigator): Medication non-compliance is estimated to cost the US healthcare system an estimated $76.6 billion a year. Approximately 10% of hospital admissions are related to medication issues, costing up to $50 billion annually. Understanding the causes of noncompliance and identifying methods to help patients follow their regimens may improve health outcomes and reduce related costs. We propose to determine whether a medication management system improves compliance among elderly patients being treated for hypertension. The medication management system, called Emedonline, uses standard cellular phone technology to call patients at programmed intervals, gives voice, text, and graphic instructions for taking prescribed medications, and dispenses the medications. It focuses specifically on modifying social interaction factors and providing a tool to enhance the administration process. We have identified three key objectives toward achieving Phase I and Phase II goals: 1. Develop Emedonline to facilitate prescribing medication regimens for healthcare providers, and facilitate medication compliance for patients. 2. Assess the acceptability of the service among healthcare providers, pharmacists, and patients. 3. Evaluate effects on medication compliance, perceived social support, and feelings of control over health destiny. During Phase I, we will examine requirements through focus groups with a sample of healthcare providers, pharmacists, and patients; develop a prototype of the Emedonline system; conduct a concept test with the sample; and create detailed specifications for Phase II development.